Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

Jeffrey A. Linder

doi:10.1086/591149

Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

Jeffrey A. Linder

Medicine, General Medicine Division

Research output: Contribution to journal › Comment/debate › peer-review

49 Scopus citations

Original language	English (US)
Pages (from-to)	744-746
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	47
Issue number	6
DOIs	https://doi.org/10.1086/591149
State	Published - Sep 15 2008

Funding

Potential conflicts of interest. J.A.L. has received grant support from Roche and Pfizer.

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1086/591149

Cite this

@article{2ca3a854f7c448d2be1d7d20e91c47f7,

title = "Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance",

author = "Linder, {Jeffrey A.}",

note = "Funding Information: Potential conflicts of interest. J.A.L. has received grant support from Roche and Pfizer.",

year = "2008",

month = sep,

day = "15",

doi = "10.1086/591149",

language = "English (US)",

volume = "47",

pages = "744--746",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Antibiotics for treatment of acute respiratory tract infections

T2 - Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

AU - Linder, Jeffrey A.

N1 - Funding Information: Potential conflicts of interest. J.A.L. has received grant support from Roche and Pfizer.

PY - 2008/9/15

Y1 - 2008/9/15

UR - http://www.scopus.com/inward/record.url?scp=51549115231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51549115231&partnerID=8YFLogxK

U2 - 10.1086/591149

DO - 10.1086/591149

M3 - Comment/debate

C2 - 18694343

AN - SCOPUS:51549115231

SN - 1058-4838

VL - 47

SP - 744

EP - 746

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this